Lipofectamine® 2000 Transfection Reagent

（Invitrogen™）

采用Lipofectamine® 2000試劑，您可以實現：

• 在各種細胞系中具有的轉染效率和高重組蛋白表達水平 （表1）

• 出眾的siRNA和質粒DNA共轉染性能

• 在血清存在時亦具有可靠的轉染效率 – 轉染后無需更換培養基

• 適用于高通量應用的可靠性能

• 建立穩定細胞系的*選擇


適用于基因表達和基因沉默的高性能轉染試劑

Lipofectamine® 2000試劑適合所有常見細胞系及許多難以轉染的細胞系，可用于含有或不含血清的培養基。在基因沉默應用中，Lipofectamine® 2000試劑的高效轉染提供了很高的基因敲除水平，足以獲得令人信服的結果。Lipofectamine® 2000試劑可實現siRNA和質粒DNA的高效轉染，它是共轉染的*試劑。Lipofectamine® 2000試劑使用方便 – 只需將其與核酸混合，加入細胞培養物即可。


適合高通量操作

Lipofectamine® 2000試劑使用簡單、快速且具有很高的轉染效率，適用于瞬時蛋白表達或高通量RNAi轉染。在上述應用中，可輕松建立自動化或機器人系統轉染條件。如需了解有關Lipofectamine® 2000的實驗方案、文獻引證及其它產品信息，可登錄細胞系數據庫。


僅供研究使用。不得用于人或動物的治療或診斷。

Description

• Lipofectamine® 2000 Transfection Reagent is a proprietary formulation

for transfecting nucleic acids （DNA, RNA, and mRNA） into a wide

range of eukaryotic cells.

• Nucleic acid-Lipofectamine® 2000 complexes can be added directly to

cells in culture medium, in the presence or absence of serum/antibiotic.

• It is not necessary to remove complexes or change/add medium after

transfection.

Important Guidelines for Transfection

• Use Opti-MEM® I Reduced Serum Medium （Cat. no. 31985-062） to

dilute Lipofectamine® 2000 Transfection Reagent and nucleic acids.

• The amount of Lipofectamine® 2000 Reagent required for successful

transfection varies depending on the cell type and passage number.

Start any new transfection by testing the recommended four

concentrations of Lipofectamine® 2000 Reagent to determine an

optimum amount.

• Prepare high-quality plasmid DNA at 0.5–5 μg/μL in deionized water

or TE buffer. A GFP （green fluorescent protein） plasmid can be used to

determine transfection efficiency.

• For additional information, and protocols on transfecting suspension

cells refer to the manual at www.lifetechnologies.com/transfection.

5

Day 2–4 Day 1 Day 0

Cells

Lipofectamine® 2000 Reagent

DNA

Seed cells so they are

70–90% confl uent at the

time of transfection.

Dilute 4 amounts of

Lipofectamine® 2000

Reagent in Opti-MEM®

Medium.

Dilute DNA in

Opti-MEM® Medium.

Add diluted DNA to

each tube of diluted

Lipofectamine® 2000

Reagent （1:1 ratio）.

Incubate.

Add DNA-reagent

complex to cells.

Visualize/analyze

transfected cells.

Plasmid Transfection

Transfect cells according to the following table. The transfection is designed

for 1 DNA amount combined with 4 different amounts of Lipofectamine®

2000. For each lipid reagent amount, the prepared mix is enough to

have triplicates （96-well）, duplicates （24-well）, and single well （6-well）

transfections, and account for pipetting variations.

Component 96-well 24-well 6-well

Adherent cells 1–4 x 104 0.5–2 x 105 0.25–1 x 106

Opti-MEM® Medium 25 μL x 4 50 μL x 4 150 μL x 4

Lipofectamine® 2000 Reagent 1, 1.5, 2, 2.5 μL 2, 3, 4, 5 μL 6, 9, 12, 15 μL

Opti-MEM® Medium 125 μL 250 μL 700 μL

DNA （0.5–5 μg/μL） 2.5 μg 5 μg 14 μg

Diluted DNA 25 μL 50 μL 150 μL

Diluted Lipofectamine® 2000

Reagent 25 μL 50 μL 150 μL

Incubate for 5 minutes at room temperature

DNA-reagent complex/well 10 μL 50 μL 250 μL

Incubate cells for 1–3 days at 37°C

Amount 96-well 24-well 6-well

DNA/well 100 ng 500 ng 2500 ng

Lipofectamine® 2000 Reagent/

well 0.2–0.5 μL 1–2.5 μL 5–12.5 μL

The following table shows the amounts of DNA and Lipofectamine®

2000 Reagent per well used in each transfection reaction. For additional

information on scaling your transfection reaction, see page 4.

For support visit www.lifetechnologies.com/support

www.lifetechnologies.com

Limited Product Warranty

Life Technologies Corporation and/or its affi liate（s） warrant their products as set forth in the Life Technologies’ General Terms and

Conditions of Sale found on Life Technologies’ website at www.lifetechnologies.com/terms and conditions. If you have any questions,

please contact Life Technologies at www.lifetechnologies.com/support.

Disclaimer: LIFE TECHNOLOGIES AND/OR ITS AFFILIATE（S） DISCLAIM ALL WARRANTIES WITH RESPECT TO THIS DOCUMENT, EXPRESSED OR IMPLIED, INCLUDING

BUT NOT LIMITED TO THOSE OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. TO THE EXTENT ALLOWED BY LAW, IN NO EVENT

SHALL LIFE TECHNOLOGIES AND/OR ITS AFFILIATE（S） BE LIABLE, WHETHER IN CONTRACT, TORT, WARRANTY, OR UNDER ANY STATUTE OR ON ANY OTHER BASIS FOR

SPECIAL, INCIDENTAL, INDIRECT, PUNITIVE, MULTIPLE OR CONSEQUENTIAL DAMAGES IN CONNECTION WITH OR ARISING FROM THIS DOCUMENT, INCLUDING BUT

NOT LIMITED TO THE USE THEREOF.

©2012 Life Technologies Corporation. All rights reserved. The trademarks mentioned herein are the property of Life Technologies Corporation or their respective owners.

*部分 invitrogen 原裝產品

第二部分 HyClone胎牛血清

第二部分  Gibco胎牛血清